The University of Chicago Header Logo

Connection

Walter M. Stadler to Cyclophosphamide

Back to Details
This is a "connection" page, showing publications Walter M. Stadler has written about Cyclophosphamide.
Walter M. Stadler
Connection Strength
0.038
Cyclophosphamide
  1. Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2. Cancer. 2019 06 01; 125(11):1830-1836.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.